Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.
about
ARID1A mutations in endometriosis-associated ovarian carcinomasAssociation between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studiesEpigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancerData set for reporting of ovary, fallopian tube and primary peritoneal carcinoma: recommendations from the International Collaboration on Cancer Reporting (ICCR)Nutlin-3a: A Potential Therapeutic Opportunity for TP53 Wild-Type Ovarian CarcinomasMalignant extracellular vesicles carrying MMP1 mRNA facilitate peritoneal dissemination in ovarian cancer.Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA.Inhibition of adhesion, proliferation, and invasion of primary endometriosis and endometrial stromal and ovarian carcinoma cells by a nonhyaluronan adhesion barrier gel.High-Throughput Amplicon-Based Copy Number Detection of 11 Genes in Formalin-Fixed Paraffin-Embedded Ovarian Tumour Samples by MLPA-Seq.GPR30 regulates the EGFR-Akt cascade and predicts lower survival in patients with ovarian cancer.Telomere length in different histologic types of ovarian carcinoma with emphasis on clear cell carcinoma.Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.Opportunistic salpingectomy for ovarian cancer preventionGenital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium.Ovarian cancer: density equalizing mapping of the global research architecture.Targeting solid tumors with non-pathogenic obligate anaerobic bacteria.Molecular abnormalities in ovarian carcinoma: clinical, morphological and therapeutic correlates.Novel insights on the malignant transformation of endometriosis into ovarian carcinoma.Cancer genomics: why rare is valuable.Targeting of follicle stimulating hormone peptide-conjugated dendrimers to ovarian cancer cells.Expression of angiogenic chemokines in ovarian clear cell carcinoma.A population-based analysis of germline BRCA1 and BRCA2 testing among ovarian cancer patients in an era of histotype-specific approaches to ovarian cancer prevention.
P2860
Q24610484-498631D9-24A9-44B5-ACAF-D553E88E708AQ24619808-59C4FE53-1321-4166-8AAF-A40DE40F3578Q24633316-3C4DE640-250D-4965-AA57-E0A761F354EDQ26852127-FF64A4A7-E341-440B-8761-210CDAB12C97Q28547093-30FEFAC2-C81F-456B-A0C9-746226995CD1Q30841262-BDB22B76-1FBF-4F60-A529-D17E57343943Q33778612-0FCA1DBE-0C05-4939-B0FB-5B07E694EE48Q35133135-7A06A3EC-E8A5-429C-88D2-40CEADD81F25Q35841629-BBD96961-B4FD-4E63-85B8-55E045D0C6BEQ36526815-2ED2929A-8FF1-41BB-BA27-AA3313C7864EQ36608043-4A0FCFC9-2A0C-4D31-825D-F59D904F5869Q36916354-35C9A353-9D2E-4C32-BECA-2A49D2B9DED3Q36938143-CFEC41C9-297D-42C9-8C88-A4B9DBAFD1D0Q37155520-95FC7200-BA0F-4F0D-BCEF-1D3EEF0D0074Q37584843-1B4A929D-F5C8-4CD6-96E5-CA67DC88EA4BQ37586630-AB690A1C-15C6-405D-B982-791D474E2558Q37767742-3E624F61-694D-480F-9F3D-AD5942156CA7Q38067436-CFE7FA69-FD4C-4846-BC2E-A62B0F9C0E1DQ38218228-00F3CA78-9946-4358-AFA9-C76F2E249746Q38353573-92654FFD-26F9-454E-BAA1-CC1B4C376CAFQ39030019-BA22CCC1-F3F1-4691-9290-3984ACC45D03Q39577538-86F9AEE0-C7A2-46C2-9B01-54D70A7208DAQ51744236-2913AB15-5CAA-459D-B4ED-FE7D9FE502FD
P2860
Molecular abnormalities in ovarian cancer subtypes other than high-grade serous carcinoma.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@ast
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@en
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@nl
type
label
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@ast
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@en
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@nl
prefLabel
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@ast
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@en
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@nl
P2860
P356
P1433
P1476
Molecular abnormalities in ova ...... n high-grade serous carcinoma.
@en
P2093
C Blake Gilks
P2860
P304
P356
10.1155/2010/740968
P577
2009-12-30T00:00:00Z